Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:1050-1056
Published online before print February 1, 2007, doi: 10.1161/01.STR.0000257967.86132.01
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/3/1050    most recent
01.STR.0000257967.86132.01v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsumoto, T.
Right arrow Articles by van Deursen, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsumoto, T.
Right arrow Articles by van Deursen, J. M.
Related Collections
Right arrow Risk Factors
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Other Vascular biology

(Stroke. 2007;38:1050.)
© 2007 American Heart Association, Inc.


Original Contributions

Aging-Associated Vascular Phenotype in Mutant Mice With Low Levels of BubR1

Takuya Matsumoto, MD; Darren J. Baker, MSc; Livius V. d’Uscio, PhD; Gazi Mozammel, PhD; Zvonimir S. Katusic, MD, PhD Jan M. van Deursen, PhD

From the Departments of Anesthesiology, Molecular Pharmacology & Experimental Therapeutics (T.M., L.V.d’U., Z.S.K.) and Pediatric & Adolescent Medicine (D.J.B., G.M., J.M.v.D.), Mayo Clinic College of Medicine, Rochester, Minn.

Correspondence to Zvonimir S. Katusic, MD, PhD, Department of Anesthesiology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905. E-mail katusic.zvonimir{at}mayo.edu, or Jan M. van Deursen, Department of Pediatrics and Adolescent Medicine, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905. E-mail vandeursen.jan@mayo.edu

Background and Purpose— Aging is a major risk for stroke and a highly complex biological process believed to involve multiple mechanisms. Mutant mice that express low levels of the spindle assembly checkpoint protein BubR1 are known to develop several aging-associated phenotypes at a very young age, including cataracts, lordokyphosis, loss of subcutaneous fat, and impaired wound healing. However, whether BubR1 acts to prevent vascular aging has not yet been established. The present study was designed to investigate the vascular phenotype of mutant mice with low levels of BubR1.

Methods— Morphological, functional, and biochemical analyses were performed on aortas and carotid arteries of 3- to 5-month-old BubR1 mutant mice and wild-type littermates.

Results— Arterial wall thickness and inner diameter were significantly reduced in BubR1 mutant mice. Arterial walls of BubR1 mutant mice had low numbers of medial smooth muscle cells. Masson trichrome staining showed profound fibrosis in arterial walls of BubR1 mutant. In agreement with these morphological changes, functional analysis of pressurized isolated carotid arteries of BubR1 mutant mice demonstrated reduced elastic properties. Endothelium-dependent relaxations to acetylcholine and endothelium-independent relaxations to the nitric oxide donor DEA-NONOate were significantly reduced in carotid arteries of BubR1 mutant mice. Furthermore, enzymatic activity of nitric oxide synthase and levels of cyclic GMP were significantly reduced in aortas of mutant mice, but production of superoxide anions was significantly increased.

Conclusions— These findings demonstrate that BubR1 insufficiency in mice results in phenotypic changes reminiscent of vascular aging in humans and suggest a role for BubR1 in suppressing the vascular aging process.


Key Words: aging • carotid arteries • endothelium • nitric oxide • nitric oxide synthase